Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Schedule of Intangible Assets Intangible Asset and Goodwill [Table Text Block] Trading Arrangement: Trading Arrangement [Axis] Maximum Maximum [Member] Statistical Measurement [Domain] Statistical Measurement [Domain] Cash and Cash Equivalents Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block] Title of 12(b) Security Title of 12(b) Security Subsequent Event Subsequent Event [Member] Numerator for diluted EPS — net income Net Income (Loss) Available to Common Stockholders, Diluted Document Fiscal Year Focus Document Fiscal Year Focus Intangible asset amortization - operating expenses Intangible Asset Amortization [Member] Intangible Asset Amortization Adjustment to Compensation, Amount Adjustment to Compensation Amount Financial Instrument [Axis] Financial Instrument [Axis] Customer [Axis] Customer [Axis] Segment Reporting [Abstract] Schedule of Future Aggregate Amortization Expense Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense [Table Text Block] Common stock, $0.001 par value; 125,000,000 shares authorized, 80,363,927 and 79,359,005 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively Common Stock, Value, Issued 2027 Lessee, Operating Lease, Liability, to be Paid, Year One Payment of taxes on vested restricted stock units Payment, Tax Withholding, Share-Based Payment Arrangement Accrued compensation expenses Employee-related Liabilities, Current Restatement Determination Date Restatement Determination Date Amendment Flag Amendment Flag Current liabilities: Liabilities, Current [Abstract] Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Treasury bills Treasury bills US Treasury Bill Securities [Member] Other cost Other Cost of Operating Revenue Loss Contingencies [Table] Loss Contingencies [Table] Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Schedule of Short-Term Investments Debt Securities, Held-to-Maturity [Table Text Block] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Entity Address, State or Province Entity Address, State or Province PEO Total Compensation Amount PEO Total Compensation Amount Common stock, par value (in USD per share) Common Stock, Par or Stated Value Per Share Assets Assets, Fair Value Disclosure [Abstract] Intangible assets, net Intangible assets, net Intangible Asset, Excluding Goodwill, after Accumulated Amortization Basic (in shares) Denominator for basic EPS — weighted average shares (in shares) Weighted Average Number of Shares Outstanding, Basic Amortization of discount on short-term investments Accretion (Amortization) of Discounts and Premiums, Investments Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Loss Contingencies [Line Items] Loss Contingencies [Line Items] Number of reporting segments Number of Reportable Segments Total current liabilities Liabilities, Current 2030 Lessee, Operating Lease, Liability, to be Paid, Year Four Entity Address, City or Town Entity Address, City or Town Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Class of Stock [Axis] Class of Stock [Axis] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Product revenue Product [Member] Net Carrying Amount Intangible Asset, Finite-Lived, after Accumulated Amortization Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Numerator for basic EPS — net income Net Income (Loss) Available to Common Stockholders, Basic Revenue Revenue from Contract with Customer Benchmark [Member] Level II Fair Value, Inputs, Level 2 [Member] Accumulated Amortization Accumulated Amortization Intangible Asset, Finite-Lived, Accumulated Amortization Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Purchases of property, plant and equipment included in accounts payable and accrued liability Capital Expenditures Incurred but Not yet Paid Schedule of Segment Reporting Information, by Segment Segment Reporting [Table Text Block] Loss on disposal of property, plant and equipment Gain (Loss) on Disposition of Property Plant Equipment Use of Estimates Use of Estimates, Policy [Policy Text Block] Revenue Recognition and Cost of Revenue Revenue from Contract with Customer [Policy Text Block] Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Stock-based compensation expense (employee) Adjustments To Additional Paid In Capital, Share Based Compensation, Employee Amount of increase in additional paid-in capital (APIC) resulting from employee stock-based compensation expense. Schedule of Future Minimum Lease Payments Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Document Period End Date Document Period End Date Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Direct expense Direct Operating Expenses Direct Operating Expenses Net cash used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding 2028 Lessee, Operating Lease, Liability, to be Paid, Year Two Percepta product technology Percepta Product Technology [Member] Percepta Technology [Member] Stockholders' Equity Equity [Text Block] Security Exchange Name Security Exchange Name License fees and royalties Cost Of Revenue, License Fees And Royalties Cost Of Revenue, License Fees And Royalties Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Shell Company Entity Shell Company Current portion of operating lease liabilities Less: short-term lease liabilities Operating Lease, Liability, Current Statement of Comprehensive Income [Abstract] Net Income Per Common Share Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Earnings (loss) per share: Earnings Per Share [Abstract] Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Total liabilities Liabilities Trading Symbol Trading Symbol Discount rate Measurement Input, Discount Rate [Member] Intangible Asset, Including Goodwill, after Accumulated Amortization [Abstract] Intangible Asset, Including Goodwill, after Accumulated Amortization [Abstract] Indefinite-lived intangible assets Intangible Asset, Excluding Goodwill, Indefinite-Lived Purchases of property, plant and equipment Payments to Acquire Property, Plant, and Equipment Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Laboratory supplies and reagents expense Cost Of Revenue, Laboratory Supplies And Reagents Expense Cost Of Revenue, Laboratory Supplies And Reagents Expense Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Allocation of facilities and IT expenses Cost Of Revenue, Allocation Of Facilities And Information Technology Expenses Cost Of Revenue, Allocation Of Facilities And Information Technology Expenses Company Selected Measure Name Company Selected Measure Name Income Tax Disclosure [Abstract] Reclassification, Type [Axis] Reclassification, Type [Axis] Intangible Asset, Indefinite-Lived [Table] Intangible Asset, Indefinite-Lived [Table] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Amortization Of Intangible Assets Amortization Of Intangible Assets [Member] Amortization Of Intangible Assets Compensation Amount Outstanding Recovery Compensation Amount Individual: Individual [Axis] Intangible Asset, Indefinite-Lived [Line Items] Intangible Asset, Indefinite-Lived [Line Items] Diluted (in shares) Denominator for diluted EPS — adjusted weighted average shares and assumed conversions (in shares) Weighted Average Number of Shares Outstanding, Diluted Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Entity Emerging Growth Company Entity Emerging Growth Company Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Property, plant and equipment, net Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization Gross Unrealized Holding Losses Debt Securities, Held-to-Maturity, Accumulated Unrecognized Loss Less: amount representing interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Common stock equivalent shares excluded from the dilutive calculation due to antidilutive effect: Antidilutive Securities Excluded From Computation Of Earnings Per Share [Abstract] Antidilutive Securities Excluded From Computation Of Earnings Per Share Other assets Increase (Decrease) in Other Noncurrent Assets Gross profit Gross Profit Other general and administrative expenses Other General and Administrative Expense Total cost of revenue Cost Of Revenue, Including Amortization Cost Of Revenue, Including Amortization Cash paid for amounts included in the measurement of lease liabilities Operating Lease, Payments C2i developed technology C2i Developed Technology [Member] C2i Developed Technology Cost of revenue: Cost of Revenue [Abstract] Award Timing Predetermined Award Timing Predetermined [Flag] Other Other Nonoperating Income (Expense), Other Other Nonoperating Income (Expense), Other Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Level I Fair Value, Inputs, Level 1 [Member] In-process research and development Software, Internally Developed [Member] Schedule of Third-party Payers as a Percentage of Total Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Organization, Consolidation and Presentation of Financial Statements [Abstract] Indefinite-lived Intangible Assets, Major Class Name [Domain] Intangible Asset, Indefinite-Lived, Class [Domain] Total future minimum lease payments Lessee, Operating Lease, Liability, to be Paid Dilutive potential common shares (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Issuance of common stock on exercise of stock options and vesting of restricted stock units (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Non-Option Equity Instruments, Exercises In Period Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Non-Option Equity Instruments, Exercises In Period All Executive Categories All Executive Categories [Member] Operating lease liabilities Increase (Decrease) in Operating Lease Liability Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Preferred stock, par value (in USD per share) Preferred Stock, Par or Stated Value Per Share Antidilutive Securities [Axis] Antidilutive Securities [Axis] Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract] Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract] Selling and marketing Total selling and marketing Selling and Marketing Expense Right-of-use assets, operating leases Operating Lease, Right-of-Use Asset Concentration Risk Type [Domain] Concentration Risk Type [Domain] Schedule of Computation of Basic and Diluted Net Earnings Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Fair Value Disclosures [Abstract] Gain (loss) on currency revaluation Other Nonoperating Income (Expense), Foreign Currency Translation Gain (Loss) Foreign Currency Translation Gain (Loss), Nonoperating Segment Segment Reporting [Text Block] Minimum Minimum [Member] Reclassification, Type [Domain] Reclassification, Type [Domain] Expiration Date Trading Arrangement Expiration Date Decrease in cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation Schedule of Revenue Disaggregation of Revenue [Table Text Block] Gross Unrealized Holding Gains Debt Securities, Held-to-Maturity, Accumulated Unrecognized Gain Effect of foreign currency on cash, cash equivalents and restricted cash Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Shares used to compute earnings (loss) per common share: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Location, Statement of Income, Balance [Axis] Location, Statement of Income, Balance [Axis] Restricted cash Restricted Cash and Cash Equivalent Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Sample collection expense Cost Of Revenue, Sample Collection Expense Cost Of Revenue, Sample Collection Expense Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Other Income and Expenses [Abstract] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Weighted Average Remaining Amortization Period (Years) Intangible Asset, Finite-Lived, Useful Life Probability of achievement Measurement Input, Probability Of Achievement [Member] Measurement input using probability of achievement. Components of Other Income Other Nonoperating Income and Expense [Text Block] Exercise Price Award Exercise Price Short-term investments Amortized Cost Debt Securities, Held-to-Maturity, Excluding Accrued Interest, after Allowance for Credit Loss Segment Reporting [Line Items] Segment Reporting [Line Items] Document Quarterly Report Document Quarterly Report Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Segments [Domain] Segments [Domain] Medicare Medicare [Member] Represents Medicare. Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Equity Component [Domain] Equity Component [Domain] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Measurement Input Type [Domain] Measurement Input Type [Domain] Issuance of common stock upon exercise of stock options and vesting of restricted stock units Share-Based Compensation Arrangement By Share-Based Payment Award, Value, Options And Non-Option Equity Instruments, Exercises In Period Share-Based Compensation Arrangement By Share-Based Payment Award, Value, Options And Non-Option Equity Instruments, Exercises In Period Other assets Loans Receivable, Fair Value Disclosure Total operating expenses Costs and Expenses Adoption Date Trading Arrangement Adoption Date Schedule of Other Income, net Schedule of Other Nonoperating Income (Expense) [Table Text Block] Total stockholders’ equity Balance at beginning of period Balance at end of period Equity, Attributable to Parent Karin Eastham [Member] Karin Eastham Assets Assets [Abstract] Title Trading Arrangement, Individual Title Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Present value of future lease payments Operating Lease, Liability Insider Trading Policies and Procedures [Line Items] Stock options and restricted stock units issued and outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Fair Value Debt Securities, Held-to-Maturity, Fair Value Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Muna Bhanji [Member] Muna Bhanji Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Business Combination [Domain] Business Combination [Domain] Deposits Security Deposit Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Anti-dilutive potential common shares (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Number of operating segments Number of Operating Segments Restricted stock units Restricted Stock Units (RSUs) [Member] Entity Central Index Key Entity Central Index Key Weighted Average Weighted Average [Member] Additional paid-in capital Additional Paid in Capital, Common Stock All Adjustments to Compensation All Adjustments to Compensation [Member] Business Combination [Axis] Business Combination [Axis] Equity [Abstract] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Net cash provided by operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Accounts Receivable Accounts Receivable [Member] Income Statement [Abstract] Income Statement [Abstract] Stockholders’ equity: Equity, Attributable to Parent [Abstract] Interest expense Other Nonoperating Income (Expense), Interest Expense Interest Expense, Nonoperating Issuance of common stock under employee stock purchase plan (ESPP) (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Document Transition Report Document Transition Report Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Operating expenses: Operating Expenses [Abstract] Thereafter Intangible Asset, Finite-Lived, Estimated Amortization Expense, After Year Four Intangible Asset, Finite-Lived, Estimated Amortization Expense, After Year Four Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] City Area Code City Area Code Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] All Individuals All Individuals [Member] Name Forgone Recovery, Individual Name Acquisition-related contingent consideration, net of current portion Business Combination, Contingent Consideration, Liability, Noncurrent Balance Sheet Related Disclosures [Abstract] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Statement [Line Items] Statement [Line Items] Total assets Assets Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Total number of shares reserved for issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Contingent consideration expense (reversal of expense) Business Combination, Contingent Consideration, Liability, Fair Value Adjustment Business Combination, Contingent Consideration, Liability, Fair Value Adjustment Issuance of common stock under employee stock purchase plan (ESPP) Stock Issued During Period, Value, Employee Stock Purchase Plan PEO PEO [Member] Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Goodwill Goodwill Contract manufacturing and testing Biopharmaceutical And Other - Contract Manufacturing And Testing [Member] Biopharmaceutical And Other - Contract Manufacturing And Testing Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Fair Value Measurement Inputs and Valuation Techniques [Line Items] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Accumulated Deficit Retained Earnings [Member] Operating lease liabilities, net of current portion Long-term lease liabilities Operating Lease, Liability, Noncurrent Intangible asset amortization - operating expenses Intangible asset amortization - operating expenses Operating Expenses Money market funds Money Market Funds [Member] Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Schedule of Fair Value Measurement Inputs and Valuation Techniques Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Common stock, shares outstanding (in shares) Balance at beginning of period (in shares) Balance at end of period (in shares) Common Stock, Shares, Outstanding Award Timing Disclosures [Line Items] Schedule of Financial Instruments Measured at Fair Value Fair Value, by Balance Sheet Grouping [Table Text Block] Diluted (in USD per share) Diluted EPS (in USD per share) Earnings Per Share, Diluted Entity Current Reporting Status Entity Current Reporting Status Net cash used in financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Total Shareholder Return Amount Total Shareholder Return Amount Tax portion of vested restricted stock units Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Liabilities Liabilities, Fair Value Disclosure [Abstract] Intangible asset amortization - operating expenses Intangible Asset, Finite-Lived, Amortization Expense Intangible Asset, Finite-Lived [Line Items] Intangible Asset, Finite-Lived [Line Items] Biopharmaceutical and other revenue Biopharmaceutical And Other [Member] Represents biopharmaceutical. Research and development Total research and development Research and Development Expense Adjustments to reconcile net income to net cash provided by operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Allocation of facilities and IT expenses Operating Expenses, Allocation Of Facilities And Information Technology Expenses Operating Expenses, Allocation Of Facilities And IT Expenses Other Testing Revenue Testing, Other [Member] Testing, Other Total revenue Revenue from Contract with Customer, Excluding Assessed Tax Financial Instruments [Domain] Financial Instruments [Domain] Intangible Asset, Finite-Lived, Class [Axis] Intangible Asset, Finite-Lived, Class [Axis] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Underlying Securities Award Underlying Securities Amount Total intangible assets Intangible Asset, Excluding Goodwill, before Accumulated Amortization Discount rate Operating Lease, Weighted Average Discount Rate, Percent Intangible asset amortization - cost of revenue Cost, Amortization Segment Reporting [Table] Segment Reporting [Table] Shares available for issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Investing activities Cash Provided by (Used in) Investing Activity, Continuing Operation [Abstract] Schedule of Operating Lease Expense and Measurement Of Lease Liabilities Lease, Cost [Table Text Block] Current portion of acquisition-related contingent consideration Business Combination, Contingent Consideration, Liability, Current Concentrations of Credit Risk and Other Risks and Uncertainties Concentrations Of Credit And Other Risks And Uncertainties [Policy Text Block] Disclosure of accounting policy for concentrations of credit risk and other risks and uncertainties. Operating activities Cash Provided by (Used in) Operating Activity, Continuing Operation [Abstract] Commitments and Contingencies Disclosure [Abstract] All Trading Arrangements All Trading Arrangements [Member] Other Performance Measure, Amount Other Performance Measure, Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Noncash lease expense Noncash Lease Expense The noncash portion of lease expense. Income (loss) from operations Operating Income (Loss) Current Fiscal Year End Date Current Fiscal Year End Date Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Entity File Number Entity File Number Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Impairment loss Impairment of assets Asset, Impairment Loss Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Common stock, shares issued (in shares) Common Stock, Shares, Issued Measure: Measure [Axis] Accrued liabilities and deferred revenue Increase (Decrease) In Accrued Liabilities And Deferred Revenue Increase (Decrease) In Accrued Liabilities And Deferred Revenue Equity Components [Axis] Equity Components [Axis] Accounts receivable Increase (Decrease) in Accounts Receivable Product and Service [Domain] Product and Service [Domain] Class of Stock [Line Items] Class of Stock [Line Items] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Entity Interactive Data Current Entity Interactive Data Current Deferred tax liabilities Deferred Income Tax Liabilities, Net Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Entity Small Business Entity Small Business Net comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent 2029 Lessee, Operating Lease, Liability, to be Paid, Year Three Termination Date Trading Arrangement Termination Date Thereafter Lessee, Operating Lease, Liability, To Be Paid, Due After Year Four Lessee, Operating Lease, Liability, To Be Paid, Due After Year Four Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Organization, Description of Business and Summary of Significant Accounting Policies Business Description and Accounting Policies [Text Block] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Other assets Other Assets, Noncurrent Financing activities Cash Provided by (Used in) Financing Activity, Continuing Operation [Abstract] Document Type Document Type Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Shares of common stock subject to outstanding options Employee And Non-Employee Stock Option [Member] An arrangement whereby an employee or non-employee is entitled to receive in the future, subject to vesting and other restrictions, number of shares in the entity at a specified price, as defined in the agreement. Accrued liabilities Total accrued liabilities Accrued Liabilities, Current Fair Value as of Grant Date Award Grant Date Fair Value Customers Representing >10% Of Total Revenue Major Customers [Member] Major Customers Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table] Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table] Number of patents allegedly infringed Loss Contingency, Patents Allegedly Infringed, Number Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Change in currency translation adjustments Currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Arrangement Duration Trading Arrangement Duration Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Decipher product technology Decipher Product Technology [Member] Decipher BioSciences Product Technology Deferred income taxes Other Noncash Deferred Income Tax Expense (Benefit) Other Noncash Deferred Income Tax Expense (Benefit) Local Phone Number Local Phone Number Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Registrant Name Entity Registrant Name Income before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Commitments and contingencies Commitments and Contingencies Gross Carrying Amount Intangible Asset, Finite-Lived, before Accumulated Amortization Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] 2030 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Four Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Executive Category: Executive Category [Axis] Liabilities and Stockholders’ Equity Liabilities and Equity [Abstract] Intangible Asset, Finite-Lived, Class [Domain] Intangible Asset, Finite-Lived, Class [Domain] Award Type [Domain] Award Type [Domain] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Remainder of 2026 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Fair Value Measurements Fair Value Disclosures [Text Block] Level III Fair Value, Inputs, Level 3 [Member] Prosigna product technology Prosigna Product Technology [Member] Prosigna Product Technology Supplies Increase (Decrease) in Materials and Supplies Settlement of escrow claims Other Nonoperating Income (Expense), Escrow Claims Settlement Other Nonoperating Income (Expense), Escrow Claims Settlement Supplementary cash flow information: Supplemental Cash Flow Information [Abstract] Other selling and marketing expenses Other Selling and Marketing Expense 2027 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year One PEO Name PEO Name John Leite [Member] John Leite Restricted cash Restricted Cash Deferred revenue Contract with Customer, Liability Short-term investments, allowance for expected credit losses Debt Securities, Held-to-Maturity, Allowance for Credit Loss, Excluding Accrued Interest Cash paid for tax Income Tax Paid, before Refund Received Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Entity Tax Identification Number Entity Tax Identification Number Measurement input Business Combination, Contingent Consideration, Liability, Measurement Input Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Total cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Schedule of Finite-Lived Intangible Assets [Table] Intangible Asset, Finite-Lived [Table] Accounts payable Increase (Decrease) in Accounts Payable Accrued other Other Accrued Liabilities, Current Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Non-NEOs Non-NEOs [Member] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Compensation expense Labor and Related Expense 2028 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Two Interest income Other Nonoperating Income (Expense), Interest Income Other Nonoperating Income (Expense), Interest Income Employee stock purchase plan Common stock available for the Employee Stock Purchase Plan Employee Stock [Member] Customer [Domain] Customer [Domain] Proceeds from maturity of short-term investments Proceeds from Maturities, Prepayments and Calls of Held-to-Maturity Securities Basic (in USD per share) Basic EPS (in USD per share) Earnings Per Share, Basic Measurement Input Type [Axis] Measurement Input Type [Axis] Current portion of deferred revenue Contract with Customer, Liability, Current Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Insider Trading Arrangements [Line Items] Cost of revenue Cost of revenue Cost of Revenue Award Type [Axis] Award Type [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Accumulated deficit Retained Earnings (Accumulated Deficit) Stock-based compensation expense (ESPP) Adjustments To Additional Paid In Capital, Share Based Compensation, ESPP Amount of increase in additional paid-in capital (APIC) resulting from ESPP stock-based compensation expense. Product and Service [Axis] Product and Service [Axis] Restricted cash Restricted Cash, Noncurrent Issuance of loan receivable Payments to Acquire Loans Receivable Revaluation of acquisition-related contingent consideration Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Common Stock Common Stock [Member] Acquisition-related contingent consideration Contingent consideration Business Combination, Contingent Consideration, Liability Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Cover [Abstract] Cover [Abstract] Reclassification Reclassification, Comparability Adjustment [Policy Text Block] Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Concentration risk Concentration Risk, Percentage Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Equity Awards Adjustments Equity Awards Adjustments [Member] Total liabilities and stockholders’ equity Liabilities and Equity Decipher trade names Decipher Trade Names [Member] Decipher Trade Names Shares of common stock subject to outstanding options Options Share-Based Payment Arrangement, Option [Member] Segments [Axis] Segments [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Tabular List, Table Tabular List [Table Text Block] Purchase of short-term investments Payments to Acquire Held-to-Maturity Securities Other income, net  Total Other income, net Other Nonoperating Income (Expense) 2029 Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Three 2026 remainder of year Intangible Asset, Finite-Lived, Estimated Amortization Expense, Remainder of Fiscal Year Name Awards Close in Time to MNPI Disclosures, Individual Name Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] NanoString NanoString [Member] Represents NanoString. General and administrative Total general and administrative General and Administrative Expense Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Supplies Inventory, Raw Materials and Supplies, Gross Preferred stock, $0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of June 30, 2026 and December 31, 2025 Preferred Stock, Value, Issued Jens Holstein [Member] Jens Holstein Adjustment to Compensation: Adjustment to Compensation [Axis] Testing revenue Testing [Member] Represents testing. Class of Stock [Domain] Class of Stock [Domain] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Schedule of Reserved Shares of Common Stock for Issuance Schedule of Stock by Class [Table Text Block] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Total assets Assets, Fair Value Disclosure Short-Term Investments Investment, Policy [Policy Text Block] Name Measure Name Income Taxes Income Tax Disclosure [Text Block] Accounts payable Accounts Payable, Current Pay vs Performance Disclosure [Line Items] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Additional Paid-in Capital Additional Paid-in Capital [Member] Entity Filer Category Entity Filer Category Short-term investments Short-Term Investments Indefinite-lived Intangible Assets [Axis] Intangible Asset, Indefinite-Lived, Class [Axis] Name Trading Arrangement, Individual Name Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalent Operating lease expense Operating Lease, Expense Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Company Selected Measure Amount Company Selected Measure Amount Depreciation and amortization Depreciation, Depletion and Amortization Entity Address, Address Line Two Entity Address, Address Line Two Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Accounts and Financing Receivables [Table] Schedule of Stock by Class [Table] Stock, Class of Stock [Table] Current assets: Assets, Current [Abstract] Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Compensation expense Cost Of Revenue, Compensation Expense Cost Of Revenue, Compensation Expense Non-PEO NEO Non-PEO NEO [Member] Entity Address, Address Line One Entity Address, Address Line One Income tax provision Income tax expense (benefit) Income Tax Expense (Benefit) Effect of foreign currency on operations Gain (Loss), Foreign Currency Transaction, before Tax Effect of potentially dilutive common stock from: Dilutive Securities, Effect on Basic Earnings Per Share [Abstract] Product costs Cost of Product and Service Sold Customer Concentration Risk Customer Concentration Risk [Member] Award Timing Method Award Timing Method [Text Block] Net decrease in cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Other research and development expenses Other Research and Development Expense Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Net income (loss) Net income (loss) Net income Net Income (Loss) Attributable to Parent Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Statement [Table] Statement [Table] Restatement Determination Date: Restatement Determination Date [Axis] Proceeds from the exercise of common stock options and employee stock purchases Proceeds from Stock Options Exercised Certificates of deposit Certificates of Deposit [Member] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] UnitedHealthcare United Healthcare [Member] Represents United Healthcare. Biopharmaceutical revenue Biopharmaceutical And Other - Biopharmaceutical Revenue [Member] Biopharmaceutical And Other - Biopharmaceutical Revenue Reportable Segment Reportable Segment [Member] Reportable Segment Revenue: Revenues [Abstract] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block]